Lufthansa, il numero uno lascia per guidare Roche


Mikkio

Utente Registrato
16 Gennaio 2009
3,783
58
Il numero uno della compagnia aerea tedesca Lufthansa, Christoph Franz lascia il suo incarico prima della scadenza del mandato del maggio 2014, per andare a guidare il gruppo farmaceutico svizzero Roche. L'uscita di scena l'annuncia Lufthansa, mentre Roche conferma che Franz sostituirà il suo capo,
Il Sole 24 Ore - leggi su http://24o.it/GgfOT
 
È iniziata la fuga pro tempore di parecchi piani alti dell'industria europea: Spinetta, Hartmann e ora Franz; chi sarà il prossimo?
 
[Mode presa per il cXXo ON]
Certo che quelli della Roche sono dei veri incompetenti, prendono uno che di farmaci non ci capisce nulla e lo mettono a capo dell'azienda. Devono fallire, anzi sono già falliti e non lo sanno. Era meglio prendere il fattorino del 3° piano, almeno lui sa che cosa è un farmaco ...
[Mode presa per il cXXo OFF]
 
[Mode presa per il cXXo ON]
Certo che quelli della Roche sono dei veri incompetenti, prendono uno che di farmaci non ci capisce nulla e lo mettono a capo dell'azienda. Devono fallire, anzi sono già falliti e non lo sanno. Era meglio prendere il fattorino del 3° piano, almeno lui sa che cosa è un farmaco ...
[Mode presa per il cXXo OFF]
:D
 
Lufthansa Boss Quits in Surprise Move to Roche Chairmanship

Deutsche Lufthansa AG (LHA) announced the surprise departure of Chief Executive Officer Christoph Franz, who will become chairman at Swiss drugmaker Roche Holding AG (ROG), leaving the German airline in limbo as it works on a turnaround.

Franz, whose term expires on May 31 next year, told Lufthansa he’s not available for an extension, the Cologne-based airline said in a statement today. The
company didn’t announce a successor. He will take over from Franz Humer, Basel-based Roche said in a separate statement.


Franz, who lives in Zurich after leading Lufthansa’s Swiss subsidiary, took the top job at Lufthansa in 2011 and embarked on a savings program that included 3,500 job cuts and a renewal of the fleet with more fuel-efficient models. Humer led Roche for more than a decade, and his departure coincides with a change of guard at cross-town rival Novartis AG (NOVN), where Daniel Vasella handed the chairman reins to Joerg Reinhardt.


“This is the right time for change in leadership,” Franz said. “Taking the decision was anything but easy after 15 years at the Lufthansa Group.”

Lufthansa rose as much as 1.7 percent and was trading 1 percent higher at 14.09 euros as of 1:03 a.m. in Frankfurt. The stock has declined 1 percent this year, valuing the airline at 6.5 billion euros ($8.7 billion). Roche rose 0.6 percent to 238.30 Swiss francs in Zurich trading, valuing the business at 205 billion francs ($221 billion).

Drug Trials


Franz will inherit a company whose success in developing and marketing new cancer drugs has been tempered by failures in other areas of research. Roche abandoned its latest experimental diabetes drug over safety concerns in July and has said it may stop trying to develop heart and metabolic drugs altogether.
Roche has said it expects eventually to face competition from cheaper biosimilar copies of its top-selling Rituxan leukemia treatment and its Herceptin breast-cancer drug. The Swiss drugmaker has sought to make newer and better drugs in each area and won U.S. approval this year for the new breast tumor drug Kadcyla.

“Franz is well-connected in Europe, and he speaks the language and knows the culture,” said Fabian Wenner, a Zurich-based analyst at Kepler Cheuvreux with a buy rating on the stock. “The question is, what can he bring Roche? Does Roche need someone who has a deeper knowledge of the pharma business? Roche is really deeply rooted in the biotech business.”


Lower Pay


Roche is also considering building its portfolio with takeovers, an area in which Humer, 67, wielded significant influence. The retiring chairman was CEO in 1999, when Roche bought a 30 percent stake in U.S. biotechnology company Genentech -- the deal that netted Roche both Herceptin and Rituxan -- and helped oversee the full takeover of the company as chairman in 2009.

Humer was paid 8.7 million francs at Roche last year, with Franz earning 2.6 million euros at Lufthansa. Franz is leaving half-way through the so-called score program, a plan to lift operating profit to a record 2.3 billion euros by 2015, which includes moving many short-haul flights to discount unit Germanwings.

Lufthansa is preparing to announce as soon as this week its biggest fleet order ever, with more than $14 billion in purchases planned from Boeing Co. (BA), the world’s biggest planemaker, and Airbus SAS, people familiar with the plan said.

The departure comes four months after Franz’s predecessor, Wolfgang Mayrhuber, withdrew his candidacy to join the supervisory board over investor opposition only to change his mind 12 hours later. Among possible successors for Franz is Carsten Spohr, who leads the Lufthansa passenger subsidiary, the company’s largest unit, and is a trained pilot.


“It’s disappointing that one of the key protagonists in pushing through the score program is departing before its completion,” said Donal O’Neill, a Dublin-based analyst at Goodbody with a buy recommendation on the stock. “But I suspect there are plenty of internal and external candidates who can take up the role.”


http://www.bloomberg.com/news/2013-...n-surprise-move-to-roche-as-new-chairman.html
 
Qualche numero sulla situazione attuale di LH pre uscita di Franz:

Lufthansa changes must continue as CEO preps to depart


Lufthansa
Group chief executive Christoph Franz is firm on the future of the German aviation group – change is critical.
“Now we are in the phase where we have to transform this programme into some kind of a permanent modus operandi of the company,” he says on the company’s Score restructuring programme during an interview with Flightglobal in New York. “There is no other way forward.”
The comments, the tune of which he has made before, come as he prepares to leave Lufthansa to become chairman of Swiss pharmaceutical company Roche when his contract expires in May 2014.
Whoever his successor is must continue the Score programme, he says. However, that decision will ultimately be up to them, he notes.
“It’s continuing to execute, continuing also to develop new ideas because the ones we are implementing are the ones we’ve already decided,” says Franz.
He continues: “When you have a programme, which is running for two or three years, and then after the third years there are no more efforts then this kind of R&D pipeline will dry up. And that is exactly the danger of many of those projects. I feel Score can be only the first milestone in a process of permanent change, which a very leading – but also legacy – carrier is going to adapt to a changing competitive environment.”
Lufthansa aims to increase operational profits to at least €2.3 billion ($3.1 billion) by 2015 from €820 million in 2011 through Score, which includes both cost cutting and efficiency improvements.
Most recently the group announced that it will outsource a third of the workforce at Lufthansa Systems, about 1,300 employees, to a third party as part of the programme.
Score reduced expenses by €171 million in the third quarter not including one-time expenses and fuel costs, the airline reported.

DEPARTURE COUNTDOWN

The announcement that Franz would leave Lufthansa came as a surprise to many when it was made public in September. His short tenure at the helm of the group as well as his departure before the completion of Score are both atypical of the company.
“The opportunity I have to take up this challenge and at the same time combined with the feeling that I have been able to contribute to the future success of Lufthansa in making sure that this will stay the leading European aviation group,” he says on his decision to leave.
The location of his family in Zurich as well as the attractiveness of the offer all contributed to the decision, he adds. He has been on the board of Roche since 2011.
Franz will continue to work on various goals and strategic initiatives that are ongoing at Lufthansa during his remaining six months with the company, he says. These include the phasing out of 70-seat aircraft from its fleet and the introduction of a new passenger service system in the middle of 2014.
One thing that has remained elusive for him is a new agreement with Lufthansa’s pilots.
“I had hoped of striking a deal already this year but so far we have not seen a positive outcome but let’s hope that it is possible to close a deal before I leave,” says Franz. “I would like to do so.”
Compromise with the pilots union Vereinigung Cockpit (VC) may be tough. It has claimed that Lufthansa’s management has created a false picture of the airline’s financial situation and cited its improving financial performance in recent years.
The group reported a 12.4% drop in operating profit to €589 million on stable operating revenues of €8.7 billion in the third quarter compared to 2012. Net profit fell more than 30% to €451 million.
Lufthansa’s passenger airline arm and low-cost subsidiary Germanwings saw operating profit increase 3.2% to €391 million during the period.
Acknowledging the surprise among many of Lufthansa’s employees at his seemingly sudden departure, he says that he could not hold both positions at once despite the rank and files’ preference for him to “stay a little bit longer”.
“This is a good Lufthansa transition,” says Franz, adding that he will help ramp-up his successor “independent of the point of departure”.
He is mum on who Lufthansa is considering as his replacement, saying only that its advisory board is considering both “valuable internal” and external candidates.
Departure or not, after more than 15 years in the airline industry with Lufthansa and its subsidiary Swiss, aviation will remain a part of Franz.
“You can imagine that an airliner leaving the airline industry is always a difficult decision,” he says. “Probably there always will be a little bit of kerosene in my blood.”

http://www.flightglobal.com/news/ar...-must-continue-as-ceo-preps-to-depart-392776/
 
Lufthansa May Name New CEO Within Fortnight

November 20, 2013
Lufthansa may name a successor to outgoing chief executive Christoph Franz in the next two weeks, two people familiar with the company's plans said.
Franz is set to leave the German carrier when his contract expires at the end of May to join Swiss pharmaceutical company Roche as chairman.
"An announcement could already be made on December 4," when Lufthansa's supervisory board is due to meet, one source said.
Under Germany's two-tier board structure, senior managers including the chief executive are appointed by the non-executive supervisory board.
"The next supervisory board meeting after that is in March, and naming a successor only next year is too long a time for the company to remain in limbo," the second person said.
German media have highlighted several Lufthansa executives as possible candidates to succeed Franz, including management board members Carsten Spohr and Harry Hohmeister, Lufthansa Cargo chief executive Karl Ulrich Garnadt and catering unit LSG's chief Walter Gehl.
Supervisory board chairman Wolfgang Mayrhuber has said the airline would also open the field to external candidates and hire a headhunter.
A spokesman for Lufthansa said: "We've said we'd take the necessary time for an extensive search inside and outside the organisation and we are doing this in an orderly process."
(Reuters)
 
Ma non è necessaria una conoscenza del settore di cui si va a fare il dirigente? farmaci o aerei o poste o ospedali o banche è tutto uguale?
 
in Italia non è usanza
Neanche all'estero:
- Richard H. Anderson, CEO di Delta da 6 anni prima era in tutt'altro campo
- Calin Rovinescu, CEO di Air Canada ha maturato l'esperienza altrove
- Christopher Luxon, CEO di Air New Zealand proviene dalla vendita di beni di consumo

giusto per nominarne alcuni.

Non serve parlare sempre per frasi fatte... ;)